Virobay has a strong intellectual property position that will support broad market exclusivity with all development compounds.
Published Virobay patent applications (other applications have publication pending).
| Patent No. | PCT Filing | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Expiration Date |
|---|---|---|---|---|---|---|---|---|
| US 7,662,849 | 04/108661 | Cysteine protease inhibitors | 06-2024 | |||||
| US 7,547,701 | 05/028429 | Cysteine protease inhibitors | 09-2024 | |||||
| US 7,737,300 | 06/034004 | Cysteine protease inhibitors | 09-2025 | |||||
| US 8,013,186 | 06/060494 | Cysteine protease inhibitors | 12-2025 | |||||
| US 8,163,735 | 06/060810 | Cysteine protease inhibitors | 12-2025 | |||||
| US 7,488,848 | 06/102243 | Cysteine protease inhibitors | 03-2026 | |||||
| US 7,893,093 | 06/102535 | Cysteine protease inhibitors | 03-2026 | |||||
| US 7,608,592 | 07/005838 | Serine protease inhibitors | 06-2026 | |||||
| US 7,781,487 | 08/042968 | Cysteine protease inhibitors | 10-2027 | |||||
| US 7,893,112 | 09/123623 | Cysteine protease inhibitors | 04-2028 | |||||
| US 8,106,059 | 09/055467 | Cysteine protease inhibitors | 10-2028 | |||||
| in prosecution | 10/056877 | Cysteine protease inhibitors | 11-2029 |